The US patent law is about to undergo a major change with a raft of reforms set to be implemented. These changes are considered to be the most comprehensive since Congress passed the 1952 patent Act. But, the path has not been smooth, with voices of dissent materializing as the government carves out its plans.
MIP and Oblon, Spivak, McClelland, Maier & Neustadt jointly hosted a roundtable discussion – at a real roundtable – in Washington DC in late summer, to discuss some of those concerns and what really needs to be done
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
With trademark volumes surging, trademark teams need to think beyond traditional clearance searches, towards a continuous, intelligence-led workflow, says Meghan Medeiros of Corsearch
Brazilian in-house counsel say law firms’ technology investments have not translated into tangible benefits, meaning tech use is a minor factor when selecting advisers
In the first of a two-part article, lawyers at Spruson & Ferguson and Marshall Gerstein provide an overview of China’s system for appealing against patent invalidation decisions
Lawyers and corporate leaders at INTA’s Business of M&A conference in New York discussed how cross-practice collaboration and early in-house involvement can help deals
Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires